Extranodal NK-/T-Cell Lymphoma, Nasal Type

Extranodal NK-/T-Cell Lymphoma, Nasal Type — Trials · CancerIndex

Clinical trials

Registered studies

23 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 100%
Top sponsor: Dren Bio
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04676789	Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL(SPENT)	unknown	Phase 2	30	Sun Yat-sen UniversityOTHER	1	Dec 21, 2020	clinicaltrials
NCT03363555	SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma	unknown	Phase 2	97	Jiangsu HengRui Medicine Co., Ltd.INDUSTRY	1	Jun 18, 2020	clinicaltrials